US Stock MarketDetailed Quotes
QNTM Quantum BioPharma
- 4.080
- -0.120-2.86%
Close Sep 18 16:00 ET
- 4.090
- +0.010+0.25%
Post 20:01 ET
6.32MMarket Cap-313P/E (TTM)
4.360High3.900Low67.36KVolume4.140Open4.200Pre Close276.32KTurnover5.49%Turnover RatioLossP/E (Static)1.55MShares97.50052wk High0.58P/B5.01MFloat Cap3.50052wk Low--Dividend TTM1.23MShs Float910.000Historical High--Div YieldTTM10.95%Amplitude3.500Historical Low4.102Avg Price1Lot Size
Quantum BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -36.45%3.47M | -75.77%2.25M | -28.65%19.57M | -71.45%1.9M | -54.35%3.31M | -25.89%5.46M | 57.63%9.3M | -18.71%27.43M | 8.84%6.66M | 41.33%7.25M |
| Selling and administrative expenses | -11.22%2.44M | -66.32%1.97M | -17.37%13.2M | -35.55%1.81M | -24.60%3.2M | -43.13%2.74M | 51.71%5.86M | -31.62%15.98M | -32.51%2.81M | 0.14%4.24M |
| -General and administrative expense | -11.22%2.44M | -66.32%1.97M | -17.37%13.2M | -35.55%1.81M | -24.60%3.2M | -43.13%2.74M | 51.71%5.86M | -31.62%15.98M | -32.51%2.81M | 0.14%4.24M |
| Research and development costs | -44.24%897.99K | -93.07%160.26K | -44.16%3.86M | -101.11%-29.96K | -101.77%-32.99K | 14.05%1.61M | 146.69%2.31M | 9.21%6.91M | 216.16%2.69M | 1,840.41%1.87M |
| Depreciation amortization depletion | -87.64%136.81K | -89.37%120.14K | -44.76%2.51M | -89.44%122.22K | -87.19%146.81K | -2.21%1.11M | 2.62%1.13M | 12.16%4.54M | 4.54%1.16M | 14.08%1.15M |
| -Depreciation and amortization | -87.64%136.81K | -89.37%120.14K | -44.76%2.51M | -89.44%122.22K | -87.19%146.81K | -2.21%1.11M | 2.62%1.13M | 12.16%4.54M | 4.54%1.16M | 14.08%1.15M |
| Operating profit | 36.45%-3.47M | 75.77%-2.25M | 28.65%-19.57M | 71.45%-1.9M | 54.35%-3.31M | 25.89%-5.46M | -57.63%-9.3M | 18.71%-27.43M | -8.84%-6.66M | -41.33%-7.25M |
| Net non-operating interest income expense | -48.40%96.07K | -41.07%160.11K | 146.48%786.06K | -48.72%153.78K | 252.80%174.45K | 1,426.42%186.16K | 1,758.37%271.67K | 568.22%318.91K | 1,126.82%299.88K | 2,626.67%49.45K |
| Non-operating interest income | -43.91%104.42K | -36.65%172.52K | 113.84%786.36K | -48.74%153.79K | 165.76%174.07K | 8,293.28%186.16K | --272.34K | 28,362.46%367.74K | --300.02K | --65.5K |
| Non-operating interest expense | --8.36K | 1,761.17%12.41K | -99.39%299 | -91.11%12 | ---- | --0 | -95.93%667 | -29.66%48.82K | -99.54%135 | 720.24%16.05K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---380 | ---- | ---- | ---- | ---- | ---- |
| Other net income (expense) | 110.41%22.33K | 100.18%1.68K | 35.97%553.46K | -54.59%96.02K | 2,545.66%2.01M | 63.12%-214.5K | -304.58%-930.28K | 422.57%407.04K | 1,514.39%211.45K | 115.79%75.83K |
| Gain on sale of security | -96.80%22.33K | 104.25%19.15K | -40.80%170.25K | 56.73%332.2K | -115.19%-5.86K | 220.04%698.1K | -221.02%-450.18K | 263.42%287.58K | 1,517.77%211.96K | 108.04%38.6K |
| Special income (charges) | --0 | 96.36%-17.48K | ---4.56M | ---236.19K | --0 | ---3.84M | ---480.1K | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --4.56M | --236.19K | --0 | ---- | ---- | --0 | --0 | --0 |
| -Less:Other special charges | ---- | --17.48K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | --0 | --0 | ---- | ---- | ---- | --3.84M | --480.1K | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | 4,034.69%4.94M | --0 | 5,303.91%2.01M | --2.93M | ---- | 139.90%119.45K | ---506 | --37.23K |
| Income before tax | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M | 84.13%-1.13M | 31.07%-5.49M | -82.34%-9.96M | 21.32%-26.7M | 0.24%-6.15M | -26.97%-7.13M |
| Income tax | ||||||||||
| Net income | 38.94%-3.35M | 79.00%-2.09M | 22.77%-18.23M | 73.14%-1.65M | 84.13%-1.13M | -24.10%-5.49M | -68.62%-9.96M | 33.10%-23.61M | 3.14%-6.15M | -23.10%-7.13M |
| Net income continuous Operations | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M | 84.13%-1.13M | 31.07%-5.49M | -82.34%-9.96M | 21.32%-26.7M | 0.24%-6.15M | -26.97%-7.13M |
| Net income discontinuous operations | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 329.83%3.1M | --0 | --0 |
| Minority interest income | -240.58K | -188.05K | -328.41K | 0 | 0 | 0 | ||||
| Net income attributable to the parent company | 43.32%-3.11M | 80.89%-1.9M | 24.17%-17.9M | 78.48%-1.32M | 84.13%-1.13M | -24.10%-5.49M | -68.62%-9.96M | 33.10%-23.61M | 3.14%-6.15M | -23.10%-7.13M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 43.32%-3.11M | 80.89%-1.9M | 24.17%-17.9M | 78.48%-1.32M | 84.13%-1.13M | -24.10%-5.49M | -68.62%-9.96M | 33.10%-23.61M | 3.14%-6.15M | -23.10%-7.13M |
| Basic earnings per share | 42.86%-5.2 | 80.77%-3.25 | 24.59%-29.9 | 75.00%-2.6 | 84.21%-1.95 | -16.67%-9.1 | -73.33%-16.9 | 39.60%-39.65 | -23.08%-10.4 | -26.67%-12.35 |
| Diluted earnings per share | 42.86%-5.2 | 80.77%-3.25 | 24.59%-29.9 | 75.00%-2.6 | 84.21%-1.95 | -16.67%-9.1 | -73.33%-16.9 | 39.60%-39.65 | -23.08%-10.4 | -26.67%-12.35 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data